CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer-Reference-Cited by-同舟云学术

CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer

Published:2018-06-20 Issue:5 Volume:45 Page:741-750
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Guembarovski Alda Losi,Guembarovski Roberta Losi,Hirata Bruna Karina Banin,Vitiello Glauco Akelinghton Freire,Suzuki Karen Mayumi,Enokida Mayara Tiemi,Watanabe Maria Angelica Ehara^ORCID,Reiche Edna Maria Vissoci

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

http://link.springer.com/article/10.1007/s11033-018-4215-7/fulltext.html

Reference57 articles.

1. Kurebayashi J (2009) Possible treatment strategies for triple-negative breast cancer on the basis of molecular characteristics. Breast Cancer 16(4):275–280. https://doi.org/10.1007/s12282-009-0111-2

2. Sleeman KE, Kendrick H, Ashworth A, Isacke CM, Smalley MJ (2006) CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast cancer research: BCR 8(1):R7. https://doi.org/10.1186/bcr1371

3. Maegawa RO, Tang SC (2010) Triple-negative breast cancer: unique biology and its management. Cancer Investig 28(8):878–883. https://doi.org/10.3109/07357907.2010.483507

4. Dawson SJ, Provenzano E, Caldas C (2009) Triple negative breast cancers: clinical and prognostic implications. Eur J Cancer 45 Suppl 1:27–40. https://doi.org/10.1016/S0959-8049(09)70013-9

5. Karnoub AE, Weinberg RA (2006) Chemokine networks and breast cancer metastasis. Breast Dis 26:75–85

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA methylation profile of inflammatory breast cancer and its impact on prognosis and outcome;Clinical Epigenetics;2024-07-06

2. New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer;Cancers;2024-06-28

3. Expression and clinical value of CXCR4 in high grade gastroenteropancreatic neuroendocrine neoplasms;Frontiers in Endocrinology;2024-03-08

4. Allelic variants and immunostaining profile in CXCL12/CXCR4 axis: An investigation of association with prognosis in prostate cancer;Pathology - Research and Practice;2023-10

5. CXCL12/CXCR4 Gene Polymorphism as a Putative Prognostic Factor for Metastasizing Breast Cancer Under Chemotherapy;Journal of Advances in Medical and Biomedical Research;2023-03-01